II. Indications
-
HIV Infection (part of combination therapy)
- High risk of induced HIV resistance
- Never use NNRTIs as monotherapy in HIV Infection
III. Mechanism
- See Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
- Second generation NNRTI
IV. Dosing
-
HIV Infection in Adult (or child weight >35 kg), in combination with other Antiretrovirals
- Take 100 mg orally daily
V. Adverse Effects
VI. Safety
- Avoid in Lactation
- Unknown safety in pregnancy (registry exists)
VII. Drug Interactions
-
Rifabutin
- Increase Doravirine frequency to 100 mg orally twice daily
-
CYP3A4 Inducers
- Avoid strong CYP3A4 Inducers with 4 weeks of Doravirine
- Examples include Carbamazepine, Phenobarbital, Phenytoin, Rifampin
-
NNRTIs
- Do not coadminister with other NNRTIs including Efavirenz, Etravirine, Nevirapine
VIII. Resources
Images: Related links to external sites (from Bing)
Related Studies
pifeltro (on 1/6/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
PIFELTRO 100 MG TABLET | $51.75 each |